Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Market Cap77.70B
Enterprise Value97.98B
Trailing P/E31.70
Forward P/E59.36

Price-Based Ratios

Valuation ratios based on stock price

Price/Sales (ttm)2.02
Forward Price/Sales1.91
Price/Book (mrq)3.01
Price/FCF (ttm)24.02
Price/OCF (ttm)17.21

Enterprise Value Ratios

EV-based valuation multiples

EV/Revenue2.54
EV/Earnings39.97
EV/EBITDA20.11
EV/EBIT27.12
EV/FCF30.29

Stock Price

Current price, 52-week range, and moving averages

Current Price$59.86
1-Day Change-4.36%
52-Week High$71.15
52-Week Low$51.20
52-Week Change-1.58%
YTD Change11.57%
1-Year Change-2.16%
50-Day MA$56.50
200-Day MA$61.71
Avg Volume (30 day)8.96M

Share Statistics

Outstanding shares, float, and per-share metrics

Shares Outstanding1.30B
Book Value per Share$19.91
Net Cash per Share$-1.43
FCF per Share$2.49

Analyst Price Targets & Consensus

Wall Street analyst ratings and 12-month price targets (90 days)

Price Target$64.10
Target Upside/Downside7.08%
Analyst ConsensusStrong Buy
Analyst Count10
View Analyst Forecast →

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Profit Margins

Profitability margins across income statement

Gross Margin28.38%
EBITDA Margin (ttm)12.64%
EBIT Margin (ttm)9.38%
Operating Margin (ttm)9.39%
Pretax Margin (ttm)7.85%
Profit Margin (ttm)6.36%
FCF Margin (ttm)8.39%

Return on Investment Metrics

ROE, ROA, ROIC, and capital efficiency ratios

Return on Equity (ttm)9.49%
Return on Assets (ttm)3.43%
Return on Invested Capital (ttm)6.35%
Return on Capital Employed (ttm)7.28%

Income Statement (TTM)

Trailing twelve months revenue and earnings

Revenue38.54B
Gross Profit10.94B
Operating Income3.62B
Pretax Income3.02B
Net Income2.45B
EBITDA4.87B
EBIT3.61B
Diluted EPS$1.90
View Full Income Statement →

Growth Rates (YoY)

Year-over-year growth metrics

Revenue Growth5.75%
Dividend Growth8.38%

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Assets & Cash

Total assets and cash positions

Total Assets (mrq)71.49B
Cash & Securities (mrq)2.13B
Net Cash (mrq)-1.86B
Net Cash per Share$-1.43
View Full Balance Sheet →

Debt & Liabilities

Liabilities, debt, equity, and working capital

Total Debt (mrq)22.40B
Working Capital (mrq)-8.91B
Total Equity (mrq)25.84B
Book Value per Share$19.91

Liquidity & Leverage

Liquidity, leverage, and debt coverage ratios

Current Ratio (mrq)0.59
Quick Ratio (mrq)0.39
Debt/Equity (mrq)0.87
Debt/EBITDA (ttm)4.60
Debt/FCF (ttm)6.93
View Full Ratios →

Dividend History & Payout Analysis

Dividend yield, payout ratios, and growth metrics

Dividend per Share (TTM)$1.94
Dividend Yield3.24%
Payout Ratio (Earnings)102.26%
Payout Ratio (FCF)77.84%
Dividend Growth (YoY)8.38%
Years of Dividend Growth11
Ex-Dividend DateDec 31, 2025
Pay DateJan 14, 2026
Dividend FrequencyQuarterly
View Dividend History →

Yield Metrics

Earnings, FCF, buyback, and shareholder yields

Earnings Yield3.15%
FCF Yield4.16%
Buyback Yield3.07%
Total Shareholder Yield6.31%

Financial Health Scores

Risk assessment and quality metrics

Altman Z-Score2.29
Piotroski F-Score3/9
Dividend Score71.86

Fair Value & Intrinsic Value

Lynch fair value, Graham number, and valuation models

Graham Number$29.15
Graham Upside/Downside-51.30%